Pharma Industry Weighs Where to Hold Its IP Amid Tariff Turmoil
Posted on
Pharma Industry Weighs Where to Hold Its IP Amid Tariff Turmoil
President Donald Trump’s tariff policies are prompting large pharmaceutical companies to promise investments in US manufacturing, but it might let them keep the crown jewels—their intellectual property—overseas.
To read more go here Subscription Required
Member Companies
